Shandwick
Executive Summary
Stephen Conafay is promoted to president-Shandwick New York and managing director-North America operations, both newly created positions. Conafay assumes increased responsibility for Shandwick North American profit and process improvement, while maintaining operating responsibility for acquisitions. Before joining the New York-based reputation management firm, Conafay was an executive fellow at the American Enterprise Institute. He has also worked for the Pharmaceutical Research & Manufacturers of America, Glaxo and Pfizer
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: